Updated: Wed, 10/02/2024 - 13:45

From Saturday, Oct. 5 through Monday, Oct. 7, the Downtown and Macdonald Campuses will be open only to McGill students, employees and essential visitors. Many classes will be held online. Remote work required where possible. See Campus Public Safety website for details.


Du samedi 5 octobre au lundi 7 octobre, le campus du centre-ville et le campus Macdonald ne seront accessibles qu’aux étudiants et aux membres du personnel de l’Université McGill, ainsi qu’aux visiteurs essentiels. De nombreux cours auront lieu en ligne. Le personnel devra travailler à distance, si possible. Voir le site Web de la Direction de la protection et de la prévention pour plus de détails.

Host Resistance - Virus

Welcome to Dr. Silvia Vidal’s Lab Homepage

SVbig
Dr. Vidal received her Ph.D. from Université de Genève in 1990. Subsequently, she did post-doctoral training in Dr. P. Gros's lab at McGill University. In 1995, Dr. Vidal started her career as an Assistant Professor in the Department of Medicine and the Department of Microbiology and Immunology of McGill University. From 1998 to 2003 she was an Assistant Professor and then an Associate Professor at the Department of Biochemistry, Microbiology and Immunology (BMI), University of Ottawa. Since 2003 Dr. Vidal has been an Associate Professor of the Departments of Human Genetics (primary appointment), Microbiology and Immunology, and Medicine of McGill University. Dr. Vidal’s research focus has been in genetic basis and molecular pathogenesis of the host response to infection with viruses. Dr. Vidal has received generous funding from various agencies to support her research including the Canadian Institute of Health Research (CIHR), the Canadian Heart and Stroke Foundation, and the Canadian Genetic Diseases Network (CGDN). During her career, Dr. Vidal has received several prestige honors and awards including Canada Research Chair in host response to viruses and Michael Smith Promising Scientist Award. Dr. Vidal is the Director of CIHR-NET for the Development of New Genetic Models of Infectious Diseases and is the leader for a team of seven research groups. Dr. Vidal has trained a number of post-doctoral fellows, graduate students and undergraduate students. Her laboratory has published more than 60 peer-reviewed papers and review articles, several of them were among the high-impact journals such as Nature Genetics, The Journal of Experimental Medicine, PLOS Pathogens and the Journal of Immunology.

Back to top